Search Results - "Mallolas, José"

Incidence and Predictors of Severe Liver Fibrosis in Human Immunodeficiency Virus—Infected Patients with Chronic Hepatitis C: A European Collaborative Study by Martín-Carbonero, Luz, Benhamou, Yves, Puoti, Massimo, Berenguer, Juan, Mallolas, José, Quereda, Carmen, Arizcorreta, Ana, Gonzalez, Antonio, Rockstroh, Jurgen, Asensi, Victor, Miralles, Pilar, Laguno, Montse, Moreno, Leonor, Girón, José Antonio, Vogel, Martin, García-Samaniego, Javier, Nuñez, Marina, Romero, Miriam, Moreno, Santiago, de la Cruz, Juan José, Soriano, Vincent

“…A study was performed in 10 European health care centers in which 914 patients coinfected with hepatitis C virus (HCV) and human immunodeficiency virus (HIV)…”
Get full text

High Incidence of Herpes Zoster in Patients with AIDS Soon After Therapy with Protease Inhibitors by Martínez, Esteban, Gatell, José, Morán, Yolanda, Aznar, Esther, Buira, Elisabet, Guelar, Ana, Mallolas, José, Soriano, Eladio

“…A high incidence of herpes zoster was noticed among patients with AIDS, shortly after addition of a protease inhibitor to their baseline treatment with…”
Get full text

Influence of Environmental Temperature on Incidence of Indinavir-Related Nephrolithiasis by Martínez, Esteban, Leguizamón, Marcelo, Mallolas, José, Miró, José M., Gatell, José M.

“…We analyzed the influence of temperature, humidity, and atmospheric pressure on the 1-year incidence of nephrolithiasis among human immunodeficiency virus type…”
Get full text

Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study by Martínez, Esteban, Mocroft, Amanda, García-Viejo, Miguel A, Pérez-Cuevas, José B, Blanco, José L, Mallolas, José, Bianchi, Luis, Conget, Ignacio, Blanch, Jordi, Phillips, Andrew, Gatell, José M

“…Risk factors for lipodystrophy in patients infected with HIV-1 treated with highly active antiretroviral therapy (HAART) containing HIV-1 protease inhibitors…”
Get full text

Randomized trial comparing pegylated interferon alpha-2b versus pegylated interferon alpha-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients by Laguno, Montserrat, Cifuentes, Carmen, Murillas, Javier, Veloso, Sergio, Larrousse, Maria, Payeras, Antoni, Bonet, Lucia, Vidal, Francese, Milinkovic, Ana, Bassa, Antoni, Villalonga, Concha, Pérez, Iñaki, Tural, Cristina, Martínez-Rebollar, Maria, Calvo, Marta, Blanco, Jose Luis, Martínez, Estaban, Sánchez-Tapias, Jose M, Gatell, Jose M, Mallolas, Jose

“…Although two pegylated interferons (Peg-IFN) are available to treat chronic hepatitis C virus (HCV) infection, no head-to-head comparative studies have been…”
Get full text

A prospective study of the risk of tuberculosis among HIV-infected patients by Guelar, A, Gatell, J M, Verdejo, J, Podzamczer, D, Lozano, L, Aznar, E, Miró, J M, Mallolas, J, Zamora, L, González, J

“…To evaluate the risk of developing active tuberculosis (TB) in a cohort of HIV-1-infected patients. Prospective longitudinal follow-up of 839 HIV-infected…”
Get more information

Septic arthritis in heroin addicts by Brancós, M A, Peris, P, Miró, J M, Monegal, A, Gatell, J M, Mallolas, J, Mensa, J, García, S, Muñoz-Gomez, J

“…Over a 6-year period (1982 to 1988), 36 episodes of septic arthritis were diagnosed in 35 heroin addicts from Barcelona, Spain. Thirty (86%) were men and five…”
Get more information

Randomized trial comparing pegylated interferon α‐2b versus pegylated interferon α‐2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients by Laguno, Montserrat, Cifuentes, Carmen, Murillas, Javier, Veloso, Sergio, Larrousse, Maria, Payeras, Antoni, Bonet, Lucia, Vidal, Francese, Milinkovic, Ana, Bassa, Antoni, Villalonga, Concha, Pérez, Iñaki, Tural, Cristina, Martínez‐Rebollar, Maria, Calvo, Marta, Blanco, Jose Luis, Martínez, Estaban, Sánchez‐Tapias, Jose M., Gatell, Jose M., Mallolas, Jose

“…Although two pegylated interferons (Peg‐IFN) are available to treat chronic hepatitis C virus (HCV) infection, no head‐to‐head comparative studies have been…”
Get full text

Influence of treatment with zidovudine (ZDV) on the long-term survival of AIDS patients by Buira, E, Gatell, J M, Miró, J M, Batalla, J, Zamora, L, Mallolas, J, Aznar, E, Soriano, E, San Miguel, J G

“…The influence of treatment with zidovudine (ZDV) and other factors on long-term survival of AIDS patients was analyzed in a cohort of 629 adults. A total of…”
Get more information

A pilot case-control study of zidovudine compared with zidovudine plus didanosine in patients with advanced HIV-1 disease and no previous experience with antiretrovirals by Gatell, J M, Leal, M, Mallolas, J, Vidal, C, Pumarola, T, Parra, R, Padró, S, Caruz, A, Falgueras, T, Rey, C, Sánchez-Quijano, A, Torres, Y, Lissen, E, Jiménez de Anta, M T, Soriano, E

“…Although zidovudine (ZDV) is effective in HIV-1-infected patients, the duration of its efficacy may be short when treatment is started in advanced HIV disease…”
Get more information

Pseudomonas aeruginosa Bacteremia: Univariate and Multivariate Analyses of Factors Influencing the Prognosis in 133 Episodes by J. Bisbe, Jose M. Gatell, Jorge Puig, Jose Mallolas, Martinez, Jose A., Maria T. Jimenez de Anta, Eladio Soriano

“…One hundred thirty-three consecutive episodes of Pseudomonas aeruginosa bacteremia were prospectively followed in a university hospital over a 36-month period…”
Get full text

Tratamiento de las infecciones oportunistas en pacientes adultos y adolescentes infectados por el virus de la inmunodeficiencia humana en la era del tratamiento antirretrovírico de gran actividad by Podzamczer, Daniel, Ramón Arribas, José, Mallolas, José, María Peña, José, Pulidod, Federico, Aguirrebengoa, Koldo, Barros, Carlos, Blazquez, Rosa, Ramón Costa, José, Dronda, Fernando, Ena, Javier, Guerrero, Antonio, Gutiérrez, Félix, Juega, Javier, Labarga, Pablo, Locutura, Jaime, López Aldeguer, José, Moreno, Santiago, Noguerado, Arturo, Ocaña, Imma, Padilla, Belén, Pérez-Cecilia, Elisa, Pérez Elías, Ma Jesús, Portilla, Joaquín, Rivero, Antonio, Roca, Victor

Get full text

Highly Active Antiretroviral Therapy (HAART) Modifies the Incidence and Outcome of Visceral Leishmaniasis in HIV-Infected Patients by Tortajada, Cecilia, Pérez-Cuevas, Bernardo, Moreno, Asuncion, Martínez, Esteban, Mallolas, Jose, Garcia, Felipe, Valls, Eugenia, Miró, José M, De Lazzari, Esther, Gatell, José M

Get full text

Prognostic factors influencing the outcome in pneumocystis carinii pneumonia in patients with AIDS by Fernandez, P, Torres, A, Miro, J M, Vieigas, C, Mallolas, J, Zamora, L, Gatell, J M, Valls, M E, Riquelme, R, Rodríguez-Roisin, R

“…BACKGROUND--Studies attempting to identify the prognostic factors that influence the outcome of Pneumocystis carinii pneumonia (PCP) in patients with AIDS…”
Get full text

Predictive factors influencing peak viral load drop in response to nucleoside reverse transcriptase inhibitors in antiretroviral-naive HIV-1-infected patients by VIDAL, C, GARCIA, F, TORTAJADA, C, GATELL, J. M, LEAL, M, CLOTET, B, PUMAROLA, T, MIRO, J. M, MALLOLAS, J, RUIZ, L, CRUCETA, A

“…Therapy with two nucleoside reverse transcriptase inhibitors (NRTI), the backbone of triple combinations, is still widely used in early stages of HIV-1…”
Get full text

Safety and Efficacy of Lamivudine-Zidovudine Combination Therapy in Antiretroviral-Naive Patients: A Randomized Controlled Comparison With Zidovudine Monotherapy by Katlama, Christine, Ingrand, Didier, Loveday, Clive, Clumeck, Nathan, Mallolas, Jose, Staszewski, Schlomo, Johnson, Margaret, Hill, Andrew M, Pearce, Gill, McDade, Hugh

“…Objective.—To compare safety and efficacy of lamivudine-zidovudine combination therapy with zidovudine monotherapy in treating human immunodeficiency virus…”
Get full text